What is the suitable Co-amoxiclav (amoxicillin-clavulanate) preparation for a 10-year-old pediatric patient weighing 37.8kg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Co-amoxiclav Dosing for a 10-year-old Pediatric Patient Weighing 37.8kg

For a 10-year-old pediatric patient weighing 37.8kg, the appropriate co-amoxiclav (amoxicillin-clavulanate) dosage is 90 mg/kg/day of the amoxicillin component divided into 2 doses, which equals approximately 1700 mg of amoxicillin per day (850 mg twice daily).

Dosage Calculation

  • Since the patient weighs 37.8kg, the daily amoxicillin component should be calculated as 90 mg/kg/day, which equals approximately 3,402 mg per day 1
  • This should be divided into two daily doses (approximately 1,701 mg per dose) 2, 1
  • The maximum daily dose of amoxicillin is 4000 mg (4g) per day, so this dosage is within safe limits 1, 3
  • For a child weighing 37.8kg, this would be equivalent to using the adult formulation since the patient weighs close to 40kg 3

Appropriate Formulation Options

  • Since the patient weighs 37.8kg (close to 40kg), they could be given the adult formulation as per FDA guidelines 3
  • The most appropriate formulation would be the 875mg/125mg tablet twice daily, which provides 1750mg of amoxicillin per day 3
  • Alternatively, the 400mg/57mg per 5mL suspension could be used, with approximately 10-11mL per dose twice daily 3

Clinical Considerations

  • Higher doses of amoxicillin (90 mg/kg/day) are recommended for respiratory tract infections due to concerns about pneumococcal resistance 1, 4
  • For more severe infections, particularly respiratory tract infections, the higher dose formulation is preferred 2, 1
  • The twice-daily regimen is associated with significantly less diarrhea than three-times-daily dosing 3

Monitoring and Follow-up

  • Children on adequate therapy should demonstrate clinical improvement within 48-72 hours 2
  • If no improvement is observed within 48-72 hours, further investigation should be performed 2
  • Monitor for common adverse effects including gastrointestinal disturbances (diarrhea, nausea, vomiting) and hypersensitivity reactions 1

Important Considerations and Pitfalls

  • Underdosing amoxicillin component is a common pitfall that should be avoided, especially in areas with high pneumococcal resistance 4
  • The 250mg/125mg tablet should not be used until the child weighs at least 40kg due to the different amoxicillin to clavulanic acid ratios 3
  • Different formulations have different ratios of amoxicillin to clavulanate, so they are not interchangeable 3
  • Patients with impaired renal function may require dose adjustment, but this is generally not necessary unless the impairment is severe 3

By following these dosing guidelines, the 10-year-old patient weighing 37.8kg should receive appropriate co-amoxiclav therapy that balances efficacy against potential pathogens while minimizing adverse effects.

References

Guideline

Amoxicillin Dosing Guidelines for Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

First-Line Antibiotic Recommendations for Pediatric Outpatients with Pneumonia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.